Immune-Oncology Scientist/Senior Scientists - Stevenage

Location
Stevenage
Salary
Competitive salary
Posted
Sep 19, 2016
Closes
Oct 17, 2016
Ref
TSK005
Result Type
Jobs
Position Type
Permanent
Hours
Full Time

Immune-Oncology Scientist/Senior Scientists


Tusk Therapeutics Ltd is harnessing the power of the innate and adaptive immune system to fight cancer.

We are establishing a diversified pipeline of antibodies against a selection of both novel and validated immuno-oncology targets that play an important role in the immune response to cancer.

The Company is headquartered in Stevenage (Greater London/Cambridge Area), United Kingdom.

Tusk Therapeutics is looking for skilled and experienced Immune-Oncology scientists and senior scientists to be part of a team developing cellular immune oncology assays for lead discovery and for determining the mode of action of our novel monoclonal antibodies. The successful candidates will also be expected to provide scientific expertise to support early project development. She/he will have a unique opportunity to learn about all aspects of therapeutic antibodies development. The successful candidates must have experience in immunology and/or oncology, either in academia or an industrial research environment. Experience in working with therapeutic antibodies and/or in cancer research as well as assay development and validation would be highly advantageous. A Ph.D in a life sciences discipline is preferred.

Please send cover letter and CV by clicking on the 'Apply' button. No recruiters. Position reference TSK005.

Apply for Immune-Oncology Scientist/Senior Scientists - Stevenage

Already uploaded your resume? Sign in to apply instantly

All answers are required

Apply
}

Upload from your computer

Or import from cloud storage

Your Resume must be a .doc, .pdf, .docx, .rtf, and no bigger than 1Mb


4000 characters left


By applying for a job listed on Chem Jobs you agree to our terms and conditions and privacy policy. You should never be required to provide bank account details. If you are, please email us.